Ri. Kelley et al., HOLOPROSENCEPHALY IN RSH SMITH-LEMLI-OPITZ-SYNDROME - DOES ABNORMAL CHOLESTEROL-METABOLISM AFFECT THE FUNCTION OF SONIC-HEDGEHOG/, American journal of medical genetics, 66(4), 1996, pp. 478-484
The RSH/Smith-Lemli-Opitz syndrome (RSH/SLOS) is an autosomal recessiv
e malformation syndrome associated with increased levels of 7-dehydroc
holesterol (7-DHC) and a defect of cholesterol biosynthesis at the lev
el of 3beta-hydroxy-steroid-triangle(7)-reductase (7-DHC reductase). B
ecause rats exposed to inhibitors of 7-DHC reductase during developmen
t have a high frequency of holoprosencephaly (HPE) [Roux et al., 1979]
, we have undertaken a search for biochemical evidence of RSH/SLOS and
other possible defects of sterol metabolism among patients with vario
us forms of HPE. We describe 4 patients, one with semilobar HPE and th
ree others with less complete forms of the HPE sequence, in whom we ha
ve made a biochemical diagnosis of RSH/SLOS. The clinical and biochemi
cal spectrum of these and other patients with RSH/SLOS suggests a role
of abnormal sterol metabolism in the pathogenesis of their malformati
ons. The association of HPE and RSH/SLOS is discussed in light of the
recent discoveries that mutations in the embryonic patterning gene, So
nic Hedgehog (SHH), can cause HPE in humans and that the sonic hedgeho
g protein product undergoes autoproteolysis to form a cholesterol-modi
fied active product. These clinical, biochemical, and molecular studie
s suggest that HPE and other malformations in SLOS may be caused by in
complete or abnormal modification of the sonic hedgehog protein and, p
ossibly, other patterning proteins of the hedgehog class, a hypothesis
testable in somatic cell systems.